Integrated genomic analyses of ovarian carcinoma.
Times cited: 2659
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA).
British Journal of Cancer.
Times cited: 11
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Nature Reviews Clinical Oncology.
Times cited: 253